Avanos Medical (AVNS) Non-Current Assets (2013 - 2026)

Avanos Medical has disclosed Non-Current Assets across 14 years of filings, most recently posting $725.1 million for Q1 2026.

• Non-Current Assets for Q1 2026 came in at $725.1 million, down 4.01% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.8 billion (down 26.8% YoY), and the FY2025 annual result was $718.3 million, down 5.59% from the prior year.
• Non-Current Assets came in at $725.1 million for Q1 2026 at Avanos Medical, up from $718.3 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $1.3 billion in Q1 2022 to a low of $683.0 million in Q2 2025.
• The 5-year median for Non-Current Assets is $1.2 billion (2024), against an average of $1.1 billion.
• Across the five-year window, Non-Current Assets rose 10.53% in 2022 and plunged 42.3% in 2025, its largest moves.
• Avanos Medical's Non-Current Assets stood at $1.2 billion in 2022, then climbed by 3.66% to $1.2 billion in 2023, then plunged by 36.88% to $760.8 million in 2024, then retreated by 5.59% to $718.3 million in 2025, then grew by 0.95% to $725.1 million in 2026.
• The last three Non-Current Assets figures came in at $725.1 million (Q1 2026), $718.3 million (Q4 2025), and $716.3 million (Q3 2025), per Business Quant data.